Drug Patent Watch

JANUARY 15, 2025

Understanding Google Patents Google Patents is a search engine that allows users to search the full text of patent documents from around the world. The pharmaceutical industry is highly dynamic, with frequent filings and updates that require timely access to information[2]. Implications for Pharmaceutical Stakeholders 1.

Drugs 53

Drugs Pharmaceuticals Engineering Research 53

Drug Target Review

JUNE 27, 2023

As we delve into an exclusive article with Dr Haley Marks, biomedical engineer, and project scientist at CNSI in UCLA, and her exceptional team. In this eBook, embark on an exploration of how cutting-edge imaging modalities can elevate your biomedical research.

Engineering 105

Engineering Drugs Pharmaceuticals Research 105

Drug Patent Watch

MARCH 3, 2025

Unlock the Power of Google Patents for Drug Patent Research As a researcher or professional in the pharmaceutical industry, staying on top of the latest developments in drug patents is crucial for making informed decisions. But with the vast amount of information available, it can be overwhelming to know where to start.

Research 52

Research Drugs Pharmaceuticals Engineering 52

Drug Target Review

JUNE 2, 2025

His journey began in the early stages of his career, initially working with small molecules as a chemical engineer in development and manufacturing. This partnership blends Lonzas manufacturing expertise with BigHats machine-learning platform for antibody engineering. BigHat is a very interesting company.

Small Molecule 52

Small Molecule Engineering Therapies Drugs 52

The Pharma Data

MAY 19, 2023

HIGH SCHOOL SCIENTISTS AND ENGINEERS WIN NEARLY $9 MILLION AT THE REGENERON INTERNATIONAL SCIENCE AND ENGINEERING FAIR 2023 Regeneron Pharmaceuticals, Inc. ” Regeneron ISEF provides a global stage for the best and brightest young scientists and engineers around the world.

Engineering 52

Engineering International Science Virus 52

Drug Patent Watch

MAY 26, 2025

With a market share of over 25% of the global pharmaceutical industry, the Swiss pharma sector is a powerhouse to be reckoned with. Is it the country's reputation for precision engineering, its stunning natural beauty, or perhaps its rich chocolate heritage? But what drives this success? The answer may surprise you.

Engineering 72

Engineering Pharmaceuticals Marketing 72

Alta Sciences

NOVEMBER 4, 2024

Case Study: How to Ensure Safety While Manufacturing Highly Potent APIs aasimakopoulos Mon, 11/04/2024 - 17:37 Highly potent active pharmaceutical ingredients (API) require careful attention to safety and handling during formulation and manufacturing. Are you working on a highly potent API? Contact us today to get your program on track.

Engineering 52

Engineering Production Compliance Laboratories 52

The Pharma Data

DECEMBER 22, 2020

SAITAMA, Japan–( BUSINESS WIRE )– After a capital increase in the initial closing of its series A round, with investments by Mitsubishi UFJ Capital and Real Tech Fund , Epsilon Molecular Engineering Inc. EME), a Saitama University -based biotechnology startup, recently had its second closing.

Engineering 52

Engineering Pharmaceuticals Drugs Protein Production 52

LifeSciVC

MAY 14, 2025

1,2,3 Among a long list of innovations, the lowest hanging fruit for commercialization is the use of microgravity-based crystallization to enhance high-value pharmaceuticals. Microgravity crystallization, in combination with modern innovations in antibody engineering (e.g., half-life extension) and formulation / delivery (e.g.,

Science 99

Science Production Research Drugs 99

Molecule Blog

MARCH 17, 2023

The Primitives of Biomedical Discovery and Development It’s noteworthy that the majority of approved medicines, around 60%, have their roots in academia, with the remaining 40% stemming from pharmaceutical research and discovery. These studies involve more in vivo testing in increasingly larger animals to evaluate safety and efficacy.

Engineering 52

Engineering Research Clinical Trials Government 52

Drug Hunter

JUNE 11, 2023

The biotechnology revolution allowed scientists to create drugs through genetic engineering and related biological processes, creating a new category of drugs known as “biologics.” The small molecules drugs of today look nothing like the molecules of the 1970s.

Small Molecule 147

Small Molecule Treatment Pharmaceuticals Engineering 147

The Pharma Data

NOVEMBER 10, 2020

Mr. Herbert is a highly experienced senior executive with a proven track record in the pharmaceutical industry. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Visit www.elektrofi.com for more information.

Pharmaceuticals 52

Pharmaceuticals Engineering Pharmaceutical Companies Production 52

The Pharma Data

JUNE 25, 2025

Salanersen was engineered as an advanced ASO therapeutic, building on Biogen’s experience with SPINRAZA. Strategic Collaboration with Ionis Pharmaceuticals Salanersen originated from Biogen’s longstanding collaboration with Ionis Pharmaceuticals, Inc. , a leader in RNA-targeted therapeutics.

Therapies 52

Therapies Trials RNA Treatment 52

The Pharma Data

OCTOBER 23, 2020

He previously helped build pharmaceutical manufacturing sites across the world, including a plant in China in the 1980s. HARRIMAN, TN, October 23, 2020 /24-7PressRelease/ — Richard M. He previously helped build pharmaceutical manufacturing sites across the world, including a plant in China in the 1980s. Source link.

Pharmaceuticals 52

Pharmaceuticals International Engineering Science 52

Drug Target Review

NOVEMBER 7, 2024

These antibodies are engineered to bind to specific cell-surface receptors in a multivalent manner, effectively cross-linking and clustering receptor complexes upon binding. Before Bayer, Judy held the role of Vice President of Pharmaceutical Operations at Pfizer, Inc./Medivation a clinical-stage biotech company in San Francisco, CA.

Disease 52

Disease Immune Response Regulations Engineering 52

The Pharma Data

JUNE 2, 2022

(Nasdaq: GILD) announced today that Stacey Ma, PhD will join the company as Executive Vice President, Pharmaceutical Development and Manufacturing, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day. Dr. Ma holds a PhD in chemical engineering from Yale University.

Science 52

Science Pharmaceuticals Engineering Production 52

The Pharma Data

JULY 2, 2025

HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the official launch of WuXiHigh™ 2.0 , a next-generation, high-throughput formulation development platform specifically engineered for high-concentration biologics. WuXi Biologics Launches WuXiHigh™ 2.0

FDA Approval 40

FDA Approval Packaging Production FDA 40

Drug Target Review

JUNE 14, 2025

I began developing my own scripts to streamline processes, which led me into scientific informatics, where I worked with pharmaceutical companies on cheminformatics. The others were data scientists or software engineers from the informatics side, who were approaching data science and AI from a different angle.

Laboratories 69

Laboratories Science Bioinformatics Molecular Biology 69

The Pharma Data

NOVEMBER 18, 2020

Hal came to the pharmaceutical business at mid-career, age 39. This work took him to some 50 countries and allowed Hal to meet pharmaceutical business leaders. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of reference value. Source link.

Pharmaceuticals 52

Pharmaceuticals International Engineering Government 52

SugarCone Biotech

JUNE 19, 2025

Finally, while there are clear front runners among the pharmaceutical companies developing targeted therapeutics for these antigens there are also emerging biotechs aggressively pursuing these targets. These are the patient’s own T cells that are engineered to express a binder to directly attack DLL3-positive cells.

Therapies 78

Therapies Clinical Trials Treatment Clinical Development 78

Drug Target Review

DECEMBER 21, 2023

As we navigate the current landscape of pharmaceutical exploration, we discern a future in which healthcare is characterised by personalised medicines and precision-targeted treatments. To provide comprehensive insights into ongoing developments, we are pleased to present the latest edition of Drug Target Review.

Drugs 98

Drugs DNA Engineering Disease 98

Drug Target Review

JUNE 27, 2023

Included in this issue: CELL AND GENE THERAPY Next Generation CAR T cells Dr John Maher, Leucid Bio SCREENING Unleashing the power of single-cell technologies and AI/ML for cell-centric drug discovery Fabrice Chouraqui, Cellarity IMAGING More than just a microscope: how advanced imaging modalities can take your pharmaceutical research to the next (..)

Drugs 97

Drugs Therapies Engineering Disease 97

The Pharma Data

SEPTEMBER 24, 2020

Photo by Raysonho @ Open Grid Scheduler / Grid Engine. It tested 10 of these products, and found that through consuming recommended serving sizes, participants could be exposed to pharmaceutical-level dosages of drugs. This work was published in Neurology Clinical Practice.

Pharmaceuticals 52

Pharmaceuticals Drugs FDA Production 52

The Pharma Data

JUNE 22, 2025

Engineered by Chugai Pharmaceutical Co., However, NXT007 takes the science a step further with refined molecular engineering aimed at achieving enhanced efficacy, longer dosing intervals, and a more predictable bleeding protection profile.

Clinical Trials 40

Clinical Trials Therapies Treatment Trials 40

Drug Target Review

MARCH 5, 2024

I embarked on a role as a radiation protection and neutron fluence engineer at a German subsidiary of a prominent French nuclear engineering firm. Much like any other engineering field in Germany, nuclear engineering is a male-dominated industry characterised by an ageing demographic. Following my Ph.D.,

Engineering 105

Engineering Production International Science 105

Elrig

JANUARY 26, 2023

CRISPR in Drug Discovery 2023: Bringing together the genome engineering community Now in its fifth year, ELRIG’s CRISPR in Drug Discovery: From Targets to Therapeutics event has become an annual highlight of the genome engineering community.

Engineering 40

Engineering Drugs Disease Research 40

Drug Target Review

OCTOBER 30, 2024

Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. He has over 20 years’ experience in biomedical research and pharmaceutical drug discovery. Schizophrenia risk from complex variation of complement component 4. 2016;530(7589):177-83. 2017;23(1):49-59. 2019;363(6423):126-7.

Treatment 105

Treatment Disease Clinical Trials Research 105

DrugBank

OCTOBER 17, 2024

By harnessing the vast amounts of data generated throughout the development pipeline, pharmaceutical companies can accelerate the discovery of novel therapies, optimize clinical trial design, enhance drug safety monitoring, and deliver personalized medicine, ultimately improving patient outcomes and transforming the future of healthcare.

Drug Development 98

Drug Development Metabolic Stability Clinical Trials Drugs 98

The Connected Lab

JUNE 2, 2021

Exploring how digital transformation will revolutionize process optimization and decision-making within the pharmaceutical industry Networked digital technologies and advanced automation are transforming pharmaceutical manufacturing , enabling efficiencies through real-time process optimization and faster decision-making.

Pharmaceuticals 52

Pharmaceuticals Laboratories Pharmaceutical Companies Production 52

Perficient: Drug Development

JANUARY 4, 2024

We believe as a leading digital consultancy that helps clients imagine, create, engineer, and run digital transformation and AI solutions, we in turn, help organizations drive growth, efficiency, and differentiation in these three areas. Contact us  now to discover how our expertise can take your business to new heights.

Engineering 72

Engineering Pharmaceuticals Production Research 72

Elrig

APRIL 26, 2024

Emerging Technologies for Sustainable Pharmaceutical & Medical Devices Manufacturing | Insights from Professor Dimitrios Lamprou Professor Dimitrios Lamprou is the Chair of Biofabrication and Advanced Manufacturing at Queen’s University Belfast. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS).

Pharmaceuticals 40

Pharmaceuticals Science Doctors Engineering 40

Drug Target Review

NOVEMBER 29, 2023

This is a key differentiation factor that sets Alchemab apart and is the engine that drives our target discovery process. In the ever-evolving pharmaceutical landscape, how does Alchemab Therapeutics balance innovative neuroscience research with a forward-looking approach to industry standards and ethical considerations?

Engineering 111

Engineering Drug Development Disease Research 111

The Pharma Data

OCTOBER 30, 2020

Khinast. GRAZ, AUSTRIA, October 30, 2020 /24-7PressRelease/ — The Research Center Pharmaceutical Engineering GmbH (RCPE), a global leader in pharmaceutical engineering sciences, has been awarded FDA funding for two projects commencing in the 4th quarter of 2020. ” Prof.

FDA 52

FDA Engineering Pharma Companies Pharmaceuticals 52

DrugBaron

OCTOBER 17, 2022

Over the next few years, the practice of asset-centric investing was honed through various iterations all designed to counter the inherent progression bias that damages returns in pharmaceutical R&D. Doing that allowed the creation of new tools that are appropriate to deploy much later in the pharmaceutical R&D process.

Pharma Companies 100

Pharma Companies Pharmaceuticals Drug Development Production 100

The Pharma Data

JUNE 18, 2025

Alnylam Elevates Dr. Pushkal Garg to Lead Unified Research and Development Organization, Signaling Strategic Expansion into Next Phase of RNAi Therapeutics Innovation Alnylam Pharmaceuticals , a global leader in RNA interference (RNAi) therapeutics, has announced the promotion of Pushkal Garg, M.D.,

RNA 40

RNA Clinical Development Science Disease 40

The Pharma Data

OCTOBER 26, 2020

27, 2020 /PRNewswire/ — Aridis Pharmaceuticals, Inc. Dr. Hasan Jafri , Chief Medical Officer of Aridis Pharmaceuticals, will be a speaker on a panel entitled “Direct Antivirals and Other Agents Against SARS-CoV2 Virus.” About Aridis Pharmaceuticals, Inc. Aridis Pharmaceuticals, Inc. SAN JOSE, Calif. ,

Pharmaceuticals 52

Pharmaceuticals Virus Hospitals Clinical Trials 52

The Pharma Data

JUNE 26, 2025

These elements collectively reduce the site’s ecological footprint while creating a healthier and more inspiring workplace for scientists, engineers, and support teams. Environmental consciousness is further evident in the facility’s energy-efficient systems, water conservation technologies, and waste management practices.

Laboratories 40

Laboratories Science Pharmaceuticals Compliance 40